GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bcl2l1 | decreases expression | ISO | Bcl2l1 (Mus musculus) | 6480464 | CTD | Sirolimus results in decreased expression of BCL2L1 mRNA; Sirolimus results in decreased expression of BCL2L1 protein | PMID:19922502 | Bcl2l1 | decreases expression | ISO | BCL2L1 (Homo sapiens) | 6480464 | CTD | Sirolimus results in decreased expression of BCL2L1 protein | PMID:15782132 | Bcl2l1 | increases expression | ISO | Bcl2l1 (Mus musculus) | 6480464 | CTD | Sirolimus results in increased expression of BCL2L1 mRNA; Sirolimus results in increased expression of BCL2L1 protein | PMID:18097008 PMID:21681844 | Bcl2l1 | multiple interactions | ISO | Bcl2l1 (Mus musculus) | 6480464 | CTD | [Sirolimus co-treated with IL2 protein] results in increased expression of BCL2L1 mRNA; Sirolimus inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein] | PMID:11355896 PMID:18789402 | Bcl2l1 | multiple interactions | ISO | BCL2L1 (Homo sapiens) | 6480464 | CTD | [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased expression of BCL2L1 protein; Sirolimus inhibits the reaction [Colistin results in decreased expression of BCL2L1 protein]; Sirolimus inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein]; Sirolimus inhibits the reaction [rebamipide results in increased expression of BCL2L1 protein] | PMID:15767555 PMID:18789402 PMID:29054700 PMID:35378205 | |
Go Back to source page | Continue to Ontology report |